EndaCof DH and Trastuzumab and Hyaluronidase
Determining the interaction of EndaCof DH and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / dihydrocodeine / phenylephrine
Brand name:
Synonyms: n.a.
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- EndaCof DH-Trastuzumab Injection (Intravenous)
- EndaCof DH-Trastuzumab Intravenous
- EndaCof DH-Trastuzumab-anns
- EndaCof DH-Trastuzumab-dkst
- EndaCof DH-Trastuzumab-dkst Intravenous
- EndaCof DH-Trasylol
- Trastuzumab and Hyaluronidase-Endacof HC
- Trastuzumab and Hyaluronidase-EndaCof-AC
- Trastuzumab and Hyaluronidase-EndaCof-C
- Trastuzumab and Hyaluronidase-EndaCof-DM
- Trastuzumab and Hyaluronidase-EndaCof-PD
- Trastuzumab and Hyaluronidase-Endal CD Syrup